🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The pharmacokinetic (PK) profile of tralokinumab (CAT-354) will be studied ...
Status
Completed
Location
Research Site
Start Date
2012-06
Trial ID
NCT01592396
Treatments Being Tested
To compare bioavailability and pharmacokinetics of CAT-354 following subcut...
Status
Completed
Location
MDS Pharma Services (US) Inc.
Start Date
2008-04-11
Trial ID
NCT00638989
Treatments Being Tested
Primary objective: To evaluate the efficacy of tralokinumab compared with ...
Status
Completed
Location
Burke Pharmaceutical Research
Start Date
2017-06-12
Trial ID
NCT03160885
Treatments Being Tested
The BioDay Registry aims to address the need for daily practice data regard...
Status
Recruiting
Location
Radboud University Medical Center
Start Date
2018-01-01
Trial ID
NCT03549416
A 52-Week, Open-Label, Multicentre Study to Evaluate the Safety of Tralokin...
Status
Terminated
Location
Research Site
Start Date
2016-11-11
Trial ID
NCT02902809
Treatments Being Tested
Hypothesis: Treatment with tralokinumab in patients with moderate-to-severe...
Status
Recruiting
Location
Department of Dermatology of the University Hospital Augsburg
Start Date
2025-10-20
Trial ID
NCT07444801
Treatments Being Tested
The aim of the study is to evaluate the efficacy and safety of tralokinumab...
Status
Completed
Location
Research Site
Start Date
2015-01-23
Trial ID
NCT02347176
Treatments Being Tested
To investigate the effects of CAT-354 on airway hyper-responsiveness (AHR) ...
Status
Terminated
Location
St. Vincents Hospital, Thoracic Medicine Unit
Start Date
2008-01
Trial ID
NCT00640016
Treatments Being Tested
The purpose of this trial is to investigate if tralokinumab changes the met...
Status
Completed
Location
LEO Pharma Investigational Site
Start Date
2018-08-13
Trial ID
NCT03556592
Treatments Being Tested
Primary objective: To evaluate the efficacy of subcutaneous (SC) administr...
Status
Completed
Location
LEO Pharma Investigational Site
Start Date
2018-06-19
Trial ID
NCT03526861
Treatments Being Tested